Showing results (21-30 of 1,391) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy EraAsaf Maoz, Leah Biller, Marios Giannakis, et al.
JCO Precision Oncology|September 26, 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian CancerChiara Maura Ciniselli, Elena Conca, Michele Bartoletti, et al.
JCO Precision Oncology|October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Gift Nyamundanda, David Cunningham, et al.
JCO Precision Oncology|October 5, 2020
Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal CancerMohamed Bouchahda, Raphael Saffroy, Abdoulaye Karaboué, et al.
JCO Precision Oncology|October 5, 2020
CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1-Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-CodeletionErik A Williams, Radwa Sharaf, Brennan Decker, et al.
JCO Precision Oncology|August 29, 2020
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene AlterationsJose Mauricio Mota, Ethan Barnett, Jones T Nauseef, et al.
JCO Precision Oncology|July 12, 2021
Tumor DNA Mutations From Intraparenchymal Brain Metastases Are Detectable in CSFStephanie Kim Cheok, Azeet Narayan, Anna Arnal-Estape, et al.
JCO Precision Oncology|July 12, 2021
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor ContentCatherine B Meador, Marina S D Milan, Emmy Y Hu, et al.
JCO Precision Oncology|July 12, 2021
Tolerability of Breast Radiotherapy Among Carriers of ATM Germline VariantsLeslie A Modlin, Jessica Flynn, Zhigang Zhang, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Pageof 140